SEC Filing Details
Document Details
Form
Filing Date
May 29, 2024
Document Date
April 08, 2024
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.